Goldsite Diagnostics Inc., is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents. Goldsite offers clinical instruments such as advanced medical laboratory analyzers that provide accurate and timely results to aid clinical diagnosis.
Goldsite provide full portfolio of biomarker in vitro diagnostic assays performed at clinical laboratory for COVID-19, infectious diseases, diabetes and more. Our current products include more than 50 assays, from inflammation, diabetes, rheumatoid diseases, immune disorders, hormones to cardiac markers.
COMPANY NEWS · MEDICA 2026 MEDICA 2026 Closes New launches and integrated Diabetes-CKD solutions Düsseldorf, Germany · 19 November 2026 · Hall 1 · Stand B56 Today marks the successful conclusion of MEDICA 2026 (16–19 November 2026, Messe Düsseldorf). Marking 27+ years
READ MORE
Goldsite Diagnostics at MEDICA 2026 | World Premiere of GSH-120 COMPANY NEWS GSH-120 Debuts at MEDICA 2026 High-Throughput Ion-Exchange HPLCHbA1c Analyzer Hall 1 · Stand B56 | 16–19 November 2026 | Messe Düsseldorf, Germany
READ MORE